Ramdas Latha, Giri Uma, Ashorn Cheryl L, Coombes Kevin R, El-Naggar Adel, Ang K Kian, Story Michael D
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Head Neck. 2009 May;31(5):642-54. doi: 10.1002/hed.21017.
The expression of miRNA in head and neck squamous cell carcinomas (HNSCCs) that had been classified as high risk by surgical pathologic features and validated by trial outcome for disease recurrence was determined and compared with matched adjacent normal tissues.
miRNA and corresponding gene expression were determined using miRNA bioarrays and gene expression arrays.
Twenty miRNAs were determined to be differentially regulated in the HNSCC samples when compared with their normal tissue counterparts. Quantitative reverse transcriptase-polymerase chain reaction confirmed differential regulation of miRNA expression, and gene expression analysis on these same-paired samples confirmed the loss of putative mRNA targets including genes such as adenomatous polyposis coli, programmed cell death protein 4, and TGF beta receptor 3 in the tumor samples.
These data suggest a role for the upregulation of specific miRNAs in high-risk HNSCC. Furthermore, upregulation of these miRNAs may be responsible for the elimination of mRNAs that lead to the growth and progression of HNSCC.
确定经手术病理特征分类为高风险并经疾病复发试验结果验证的头颈部鳞状细胞癌(HNSCC)中miRNA的表达,并与匹配的相邻正常组织进行比较。
使用miRNA生物芯片和基因表达芯片确定miRNA和相应基因的表达。
与正常组织对应物相比,确定20种miRNA在HNSCC样本中存在差异调节。定量逆转录聚合酶链反应证实了miRNA表达的差异调节,对这些配对样本的基因表达分析证实了肿瘤样本中假定mRNA靶标的缺失,包括腺瘤性息肉病基因、程序性细胞死亡蛋白4和TGFβ受体3等基因。
这些数据表明特定miRNA的上调在高风险HNSCC中起作用。此外,这些miRNA的上调可能导致导致HNSCC生长和进展的mRNA的消除。